Millennium Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $990K | Buy |
58,204
+21,724
| +60% | +$370K | ﹤0.01% | 3035 |
|
2025
Q1 | $712K | Sell |
36,480
-38,873
| -52% | -$759K | ﹤0.01% | 3141 |
|
2024
Q4 | $1.87M | Sell |
75,353
-6,364
| -8% | -$158K | ﹤0.01% | 2555 |
|
2024
Q3 | $2M | Buy |
81,717
+873
| +1% | +$21.4K | ﹤0.01% | 2547 |
|
2024
Q2 | $1.89M | Sell |
80,844
-26,343
| -25% | -$617K | ﹤0.01% | 2517 |
|
2024
Q1 | $3.54M | Buy |
107,187
+31,478
| +42% | +$1.04M | ﹤0.01% | 2235 |
|
2023
Q4 | $2.06M | Sell |
75,709
-67,722
| -47% | -$1.84M | ﹤0.01% | 2437 |
|
2023
Q3 | $3.45M | Sell |
143,431
-52,100
| -27% | -$1.25M | ﹤0.01% | 2144 |
|
2023
Q2 | $6.24M | Buy |
195,531
+2,531
| +1% | +$80.8K | ﹤0.01% | 1774 |
|
2023
Q1 | $5.91M | Buy |
193,000
+113,846
| +144% | +$3.49M | ﹤0.01% | 1812 |
|
2022
Q4 | $3.1M | Sell |
79,154
-88,951
| -53% | -$3.48M | ﹤0.01% | 2420 |
|
2022
Q3 | $8.01M | Sell |
168,105
-232,258
| -58% | -$11.1M | ﹤0.01% | 1806 |
|
2022
Q2 | $15.5M | Sell |
400,363
-177,698
| -31% | -$6.88M | 0.01% | 1107 |
|
2022
Q1 | $33.1M | Buy |
578,061
+437,411
| +311% | +$25.1M | 0.02% | 622 |
|
2021
Q4 | $11.2M | Sell |
140,650
-86,339
| -38% | -$6.88M | 0.01% | 1479 |
|
2021
Q3 | $19.8M | Buy |
226,989
+131,294
| +137% | +$11.4M | 0.01% | 909 |
|
2021
Q2 | $12.3M | Sell |
95,695
-98,600
| -51% | -$12.7M | 0.01% | 1209 |
|
2021
Q1 | $14.8M | Buy |
194,295
+149,824
| +337% | +$11.4M | 0.01% | 1035 |
|
2020
Q4 | $3.63M | Buy |
+44,471
| New | +$3.63M | ﹤0.01% | 2129 |
|
2020
Q3 | – | Sell |
-338,645
| Closed | -$9.48M | – | 3605 |
|
2020
Q2 | $9.48M | Buy |
338,645
+125,540
| +59% | +$3.52M | 0.01% | 979 |
|
2020
Q1 | $3.84M | Buy |
+213,105
| New | +$3.84M | 0.01% | 1232 |
|